Chemours (CC) PT Lowered to $19 at UBS
Tweet
Share
E-mail
Get Alerts CC Hot Sheet
Price: $15.61 -1.89%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 20
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 20
Join SI Premium – FREE
UBS analyst John Roberts lowered the price target on Chemours (NYSE: CC) to $19.00 (from $21.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
- NetEase.com (NTES) PT Raised to $168 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
